SAPPHIRE

Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress

Retrieved on: 
Tuesday, March 19, 2024
Research, FDA, Clinical Trials, Cardiology, Biotechnology, Pharmaceutical, Health, Science, Oncology, Other Science, Overweight, SMN, Conference, Obesity, Keystone, MDA, Gilead Sciences, SAPPHIRE, SMA, Manuscript, Myostatin, Rock, Muscular dystrophy, Muscular Dystrophy Association, Trial of the century, Efficacy, Clinical trial, Therapy, Literature, Lunch, Pharmaceutical industry

“In 2023, Scholar Rock made significant progress across our industry-leading antimyostatin pipeline, and we are poised for a transformational year ahead.

Key Points: 
  • “In 2023, Scholar Rock made significant progress across our industry-leading antimyostatin pipeline, and we are poised for a transformational year ahead.
  • Scholar Rock remains on track to report topline data from the Phase 3 trial in the fourth quarter of 2024.
  • Scholar Rock also presented a literature review that describes the ongoing burden and significant unmet needs in SMA despite advancements in treatment.
  • Dr. Qatanani joined Scholar Rock in 2021 and has been leading all research functions since 2022 and driving Scholar Rock’s early-stage pipeline, including SRK-439.

Scholar Rock Provides Corporate Update and Highlights Priorities for 2024

Retrieved on: 
Thursday, January 4, 2024
Research, Neurology, Diabetes, Clinical Trials, Cardiology, Biotechnology, Managed Care, Pharmaceutical, Health, Science, Conference, Cure, IND, SAPPHIRE, Spinal muscular atrophy, Clinical trial, Obesity, Standard of care, Annual general meeting, Gongshi, Consequence, Myostatin, DRAGON, Webcast, MPH, Patient, Rock, SMN, SMA, Renal cell carcinoma, SITC, Pharmaceutical industry

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today provided recent corporate updates and highlighted upcoming priorities for 2024.

Key Points: 
  • Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today provided recent corporate updates and highlighted upcoming priorities for 2024.
  • Planning to announce Phase 3 SAPPHIRE clinical trial topline data in 4Q 2024.
  • Scholar Rock management will highlight these updates in a corporate presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. PT (4:30 p.m.
  • A live webcast of the presentation may be accessed by visiting the Investors & Media section of the Scholar Rock website at http://investors.scholarrock.com .

Bacardi Gifting Celebrates Sustainability Landmark

Retrieved on: 
Tuesday, November 28, 2023
Other Retail, Professional Services, Wine & Spirits, Recycling, Sustainability, Specialty, Food, Beverage, Other Manufacturing, Environment, Retail, Packaging, Environmental, Social and Governance (ESG), Manufacturing, Social, Quality, SAPPHIRE, Into the Woods, Bacardi, Multimedia, PEFC, Forest Stewardship Council, ESG, Bottled water

View the full release here: https://www.businesswire.com/news/home/20231128855110/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231128855110/en/
    The new limited-edition label for Bacardi-owned BOMBAY SAPPHIRE eliminates the need for a gift pack.
  • (Photo: Business Wire)
    Four years ago, Bacardi set itself the ambitious goal of removing 100% of the single-use plastic from its gifting range by the end of 2023.
  • “We are incredibly proud of what we have achieved to date but we want to go one step further,” said Rodolfo Nervi, Vice President Safety, Quality and Sustainability for Bacardi.
  • Find out more about Bacardi and its ESG – Environmental, Social & Governance – commitments, including its alignment with the United Nations Sustainable Development Goals, at www.bacardilimited.com/good-spirited .

BOMBAY SAPPHIRE® AND CHRISTIAN SIRIANO UNVEIL A FIRST OF ITS KIND COCKTAIL ATTIRE INSPIRED BY CLASSIC GIN DRINKS

Retrieved on: 
Thursday, December 7, 2023
GLAAD, Creativity, Couture, SAPPHIRE, Beauty, Collection, Bombay Sapphire, LGBTQ, System, New York Fashion Week, Partnership, Jewellery, Siriano

HAMILTON, Bermuda, Dec. 7, 2023 /PRNewswire/ -- BOMBAY SAPPHIRE® is thrilled to announce the continuation of its partnership with renowned fashion designer Christian Siriano for the launch of its cocktail-inspired capsule collection. Literally and figuratively embodying holiday cocktail party attire, this curated ensemble builds on the success of Siriano's Bombay Sapphire French 75-inspired haute couture gown showcased at his 15th-anniversary show at New York Fashion Week this past September.

Key Points: 
  • As part of BOMBAY SAPPHIRE's Saw This, Made This campaign, the collection showcases how visual inspiration can be transformed into tangible, one-of-a-kind creations.
  • Bombay Sapphire & Tonic Blouse: A shimmering blouse with pearl-white buttons down the front, capturing the effervescence of the Bombay Gin & Tonic – a holiday classic form that can be tailored according to the occasion.
  • Through innovative design and inspired silhouettes, Siriano seamlessly translates the allure of BOMBAY SAPPHIRE cocktails into the realm of high fashion."
  • This collaboration with BOMBAY SAPPHIRE allowed me to weave the narratives of iconic gin cocktails into the very fabric of style.

Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress

Retrieved on: 
Tuesday, November 7, 2023
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Gongshi, Myostatin, SMN, SAPPHIRE, IND, PIN, MPH, Obesity, Pembrolizumab, Maintenance, SITC, Rock, DRAGON, Clinical trial, Neoplasm, Webcast, Annual general meeting, ORR, Renal cell carcinoma, SMA, Patient, Pharmaceutical industry, Cryptocurrency

The Company announced that it completed enrollment in September 2023, with topline data expected in the fourth quarter of 2024.

Key Points: 
  • The Company announced that it completed enrollment in September 2023, with topline data expected in the fourth quarter of 2024.
  • Research and development expense was $30.3 million for the quarter ended September 30, 2023, compared to $33.4 million for the quarter ended September 30, 2022.
  • General and administrative expense was $13.3 million for the quarter ended September 30, 2023, compared to $10.5 million for the quarter ended September 30, 2022.
  • A live webcast of the conference call will be available on the Investors & Media section of the Scholar Rock website at http://investors.scholarrock.com .

MGM RESORTS GOES FULL THROTTLE FOR FORMULA 1 HEINEKEN SILVER LAS VEGAS GRAND PRIX

Retrieved on: 
Thursday, October 19, 2023
Caviar, Credible, LE, MARQUEE, Alfa Romeo, Omakase, The Roku Channel, Bocuse, WINE, Golden Age, Chicken parmesan, MGM, Nelk, Carbone, KENT, Chandelier, SAPPHIRE, ALFA, Iron Chef America, Justin Credible, Las Vegas Grand Prix, Glass, F1, ART, Ottawa Race Weekend, Stelvio, Worldwide Angel, DNA, Taste, MGM Resorts International, Beauty, Food, Verbena, Park MGM, ARIA, Le Cirque, Kent, Level 2, Alpine F1 Team, Restaurant, Veuve Clicquot, LINE, Ferrari, Artifact, Woman, Snack, Wine, LAS, CHEF, NYSE, BAR, Alfa Romeo Tonale, Seafood, Beer, Grand Prix, Disc jockey, Creativity, Alfa Romeo in Formula One, MAMA, Fisher, AR, Michelin, MGM Grand, HELMET, Hotel, Nightclub, Bellagio

LAS VEGAS, Oct. 19, 2023 /PRNewswire/ -- MGM Resorts International (NYSE: MGM) is putting the pedal to the metal for the FORMULA 1 HEINEKEN SILVER LAS VEGAS GRAND PRIX weekend November 16-18, creating exclusive events, one-of-a-kind activations, artist engagements and more that will take over The Strip throughout race week.

Key Points: 
  • LAS VEGAS, Oct. 19, 2023 /PRNewswire/ -- MGM Resorts International (NYSE: MGM) is putting the pedal to the metal for the FORMULA 1 HEINEKEN SILVER LAS VEGAS GRAND PRIX weekend November 16-18, creating exclusive events, one-of-a-kind activations, artist engagements and more that will take over The Strip throughout race week.
  • The Shoey Bar will be in Bellagio's Fountain Courtyard adjacent to the main valet, just steps from the Bellagio Fountain Club.
  • Bellagio guests will be able to immerse themselves in the world of the Ferrari fashion collection from November 13-20.
  • For this special event weekend, many of MGM Resorts' award-winning restaurants will open early with specialty brunch menus.

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders

Retrieved on: 
Wednesday, October 11, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Cardiology, Cardiovascular disease, Senior, Cancer, Obesity, Weight loss, IND, SAPPHIRE, Rock, Myostatin, Type 2 diabetes, Facial muscles, Maintenance, Clinical trial, Mace Head Atmospheric Research Station, SMA, Patient, Pharmaceutical industry, Vaccine, Gongshi, Research

Data from the clinical trial are expected in mid-2025 and will be used to inform further clinical development of SRK-439.

Key Points: 
  • Data from the clinical trial are expected in mid-2025 and will be used to inform further clinical development of SRK-439.
  • “As a long-standing leader in targeting myostatin with a highly selective antibody platform, we are excited to advance our cardiometabolic program.
  • Leveraging proven expertise in antimyostatin and its effect on increasing muscle mass, the Company has been developing myostatin-selective inhibitors to address cardiometabolic disorders, including obesity.
  • The Company believes the selectivity of these antibody candidates enables a favorable risk-benefit profile for patients with cardiometabolic disorders.

xSuite Nordics Joins the SAP SBN User Conference 2023

Retrieved on: 
Tuesday, September 26, 2023
Technology, Software, Cloud, BTP, Communication, SAPPHIRE, SAP, APIA, Esri International User Conference, P2P, Conference, Maple syrup

The User Conference offers visitors a platform for knowledge exchange and networking with SAP experts and SAP partner companies.

Key Points: 
  • The User Conference offers visitors a platform for knowledge exchange and networking with SAP experts and SAP partner companies.
  • Therefore SAP encourages its customers to replace previous individual SAP landscapes based on user exits with a “clean core” characterized by standardization.
  • The SAP Business Technology Platform (BTP), which SAP envisages as the future basis for SAP business processes, meets all the requirements for this.
  • The software developer will present its solutions at the SBN User Conference 2023 on booth S1.

Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial

Retrieved on: 
Tuesday, September 19, 2023
Health, Genetics, Clinical Trials, General Health, Pharmaceutical, Biotechnology, SMN, SMA, Pediatrics, SAPPHIRE, Publication, Rock, Johns Hopkins University, Patient, Neurology, MPH, Poster, Safety, Fatigue, Pharmaceutical industry, Q4

Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced today that it has completed enrollment of the SAPPHIRE Phase 3 trial evaluating the safety and efficacy of apitegromab in nonambulatory patients with Types 2 and 3 spinal muscular atrophy (SMA) who are receiving SMN therapy (either nusinersen or risdiplam).

Key Points: 
  • Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced today that it has completed enrollment of the SAPPHIRE Phase 3 trial evaluating the safety and efficacy of apitegromab in nonambulatory patients with Types 2 and 3 spinal muscular atrophy (SMA) who are receiving SMN therapy (either nusinersen or risdiplam).
  • The company also announced that it plans to present encore data from its Phase 2 TOPAZ trial extension period evaluating patient outcomes in SMA after 36 months of treatment with apitegromab.
  • “Completing SAPPHIRE enrollment is a critical step on the path to bringing apitegromab, a potentially transformative therapy, to individuals living with SMA.
  • SAPPHIRE was designed to build on the positive TOPAZ results, and we look forward to reporting the topline results from this registrational study in Q4 next year,” said Jay Backstrom, M.D., MPH, President and Chief Executive Officer of Scholar Rock.

BOMBAY SAPPHIRE® AND CHRISTIAN SIRIANO LAUNCH A FIRST-OF-ITS-KIND COCKTAIL COUTURE COLLECTION FOR THE NEXT EVOLUTION OF THE BRAND'S 'SAW THIS, MADE THIS' CREATIVE CAMPAIGN

Retrieved on: 
Monday, September 11, 2023
NYFW, Partnership, SAPPHIRE, Martini, Creativity, I Saw the Figure 5 in Gold, Collection, MARTINI, Bombay Sapphire, The Pierre, Imagination, Fashion design, Film industry, Siriano

HAMILTON, Bermuda, Sept. 11, 2023 /PRNewswire/ -- BOMBAY SAPPHIRE® announces the continuation of the brand's 'Saw This, Made This' campaign by partnering with legendary fashion designer and creative visionary Christian Siriano to create a cocktail couture collection. Renowned for his boundary-pushing designs and inclusive approach to fashion, Siriano took inspiration from iconic BOMBAY SAPPHIRE gin cocktails to create a French 75-inspired haute couture gown, which took center stage at the brand's Spring/Summer 2024 NYFW show Friday at The Pierre Hotel in New York City, as well as a gin cocktail attire capsule collection to release in time for the holiday season.

Key Points: 
  • HAMILTON, Bermuda, Sept. 11, 2023 /PRNewswire/ -- BOMBAY SAPPHIRE® announces the continuation of the brand's 'Saw This, Made This' campaign by partnering with legendary fashion designer and creative visionary Christian Siriano to create a cocktail couture collection.
  • Siriano's French 75-inspired gown was designed with flourishes that transmute the celebratory cocktail's zip of bubbles, tang of lemon juice, and bright notes of gin.
  • The perfect gift for fashion and spirits lovers alike, the collection will be available to purchase this autumn on ChristianSiriano.com.
  • Partnering with Bombay Sapphire for the 'Saw This, Made This' campaign has allowed me to design a collection that transforms classic cocktail culture into fashion.